The mechanism of the loss of efficacy has not been clarified, but it has been recently reported that pancreas-specific activation of GK causes hyperglycemia associated with dysfunction and death of β-cells in transgenic mice with an activating mutation [28]. Here, GK is linked to Hyperglycemia.